We are live on ! Find out more
SAM

Smithbridge Asset Management Portfolio holdings

AUM $734M
1-Year Est. Return 34.06%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+34.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$399M
AUM Growth
+$22.4M
Cap. Flow
+$1.56M
Cap. Flow %
0.39%
Top 10 Hldgs %
28.58%
Holding
144
New
8
Increased
60
Reduced
55
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Healthcare 19.07%
3 Industrials 9.37%
4 Financials 9.24%
5 Consumer Discretionary 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
26
T. Rowe Price
TROW
$26.1B
$5.05M 1.27%
44,753
+362
+0.8% +$41.4K
URI icon
27
United Rentals
URI
$67.9B
$4.91M 1.23%
12,401
+123
+1% +$51.7K
SCHM icon
28
Schwab US Mid-Cap ETF
SCHM
$14.5B
$4.77M 1.2%
210,957
+1,584
+0.8% +$36.5K
IVV icon
29
iShares Core S&P 500 ETF
IVV
$871B
$4.6M 1.15%
11,188
-1,817
-14% -$728K
PEP icon
30
PepsiCo
PEP
$195B
$4.55M 1.14%
24,951
+1,430
+6% +$250K
ABT icon
31
Abbott
ABT
$187B
$4.52M 1.13%
44,640
+309
+0.7% +$32.6K
ON icon
32
ON Semiconductor
ON
$32.8B
$4.39M 1.1%
53,357
+1,097
+2% +$83.3K
TMO icon
33
Thermo Fisher Scientific
TMO
$214B
$4.37M 1.1%
7,586
+104
+1% +$58.6K
EES icon
34
WisdomTree US SmallCap Earnings Fund
EES
$727M
$4.18M 1.05%
96,825
-3,164
-3% -$143K
SPYV icon
35
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
$4.12M 1.03%
101,270
+1,337
+1% +$54.2K
NVS icon
36
Novartis
NVS
$304B
$3.86M 0.97%
41,997
+1,370
+3% +$120K
MDT icon
37
Medtronic
MDT
$111B
$3.81M 0.96%
47,243
+4,255
+10% +$347K
NVDA icon
38
NVIDIA
NVDA
$4.77T
$3.81M 0.96%
137,050
+500
+0.4% +$10.8K
LLY icon
39
Eli Lilly
LLY
$1.09T
$3.81M 0.95%
11,079
+81
+0.7% +$27.3K
ECL icon
40
Ecolab
ECL
$79.6B
$3.7M 0.93%
22,366
+113
+0.5% +$17.6K
CNI icon
41
Canadian National Railway
CNI
$78.3B
$3.63M 0.91%
30,815
-284
-0.9% -$33.6K
REGN icon
42
Regeneron Pharmaceuticals
REGN
$72.9B
$3.63M 0.91%
4,422
+146
+3% +$110K
IJH icon
43
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.54M 0.89%
70,705
-32,220
-31% -$1.64M
ENPH icon
44
Enphase Energy
ENPH
$4.79B
$3.53M 0.89%
+16,806
New +$3.64M
SHW icon
45
Sherwin-Williams
SHW
$87.4B
$3.52M 0.88%
15,643
+156
+1% +$35.7K
OXY icon
46
Occidental Petroleum
OXY
$53.6B
$3.44M 0.86%
55,141
+707
+1% +$43.9K
GOOGL icon
47
Alphabet (Google) Class A
GOOGL
$4.08T
$3.43M 0.86%
33,036
+8
+0% +$767
IJR icon
48
iShares Core S&P Small-Cap ETF
IJR
$110B
$3.33M 0.84%
34,419
-11,931
-26% -$1.19M
CVS icon
49
CVS Health
CVS
$140B
$3.2M 0.8%
43,068
+137
+0.3% +$11.5K
LSTR icon
50
Landstar System
LSTR
$6.29B
$3.13M 0.79%
17,462
+16
+0.1% +$2.81K

Similar funds

Smithbridge Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Smithbridge Asset Management held 144 positions worth $399M, up 5.9% from $376M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Smithbridge Asset Management's Q1 2023 filing shows 8 new, 60 increased, 55 reduced and 4 closed positions. Its largest new stake was Enphase Energy: 16,806 shares worth $3.53M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Smithbridge Asset Management's largest Q1 2023 buy was Enphase Energy: 16,806 shares worth $3.53M.
  • Smithbridge Asset Management added most to Amazon in Q1 2023, an estimated $660K increase.
  • Smithbridge Asset Management's biggest Q1 2023 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.64M.
  • Smithbridge Asset Management fully exited State Street Health Care Select Sector SPDR ETF in Q1 2023, selling an estimated $1.46M.
  • Smithbridge Asset Management's ten largest holdings make up 29% of its $399M portfolio in Q1 2023.
  • Smithbridge Asset Management opened 8 new positions and closed 4 in Q1 2023.
  • Smithbridge Asset Management's portfolio value rose 5.9% quarter-over-quarter to $399M.

Based on Smithbridge Asset Management's 13F filing for Q1 2023, filed 20 Apr 2023.